Podcasts about bluhm cardiovascular institute

Tales From the Heart host Lisa Salberg sits down to discuss HCM with Dr. Lubna Choudhury from Northwestern Medicine's Bluhm Cardiovascular Institute.   This conversation was recorded Feb. 27, 2025.

In this special American Heart Month episode, Lance Burrell—nuclear medicine technologist and SNMMI Research and Discovery imaging specialist—sits down with Dr. Richard Weinberg, MD, PhD, the Medical Director of Nuclear Cardiology at Northwestern's Bluhm Cardiovascular Institute and President of the SNMMI Cardiovascular Council. Dr. Weinberg shares expert insights on the critical role of nuclear medicine in heart health, the latest advancements in nuclear cardiology, and the power of prevention in cardiovascular care.

The executive director of Northwestern Medicine Bluhm Cardiovascular Institute Dr. Patrick McCarthy joins Lisa Dent to share the amazing story of how the institute began and how they are now celebrating 20 years of saving lives.

In this episode, Dr. Patrick McCarthy, Executive Director of Northwestern Medicine Bluhm Cardiovascular Institute, joins Scott Becker to discuss the institute's 20-year legacy, groundbreaking innovations in heart care, and the impact of AI and GLP-1 medications on cardiovascular health.

In this episode, Laura Dyrda speaks with Samantha Yang, Project Manager at Northwestern Medicine Bluhm Cardiovascular Institute. Samantha shares her career journey, the value of mentorship, and strategies for nurturing emerging leaders in healthcare. Tune in to hear her thoughts on adaptability, self-reflection, and building diverse talent pipelines to shape the future of healthcare leadership.

In this Better Edge episode, Mohamed Al-Kazaz, MD, and Paul C. Cremer, MD, share insights on how the Northwestern Medicine Pericardial Disease Program at Bluhm Cardiovascular Institute offers comprehensive evaluations. This key offering helps uncover alternative treatment options for high-risk patients past the first-line treatments for acute and recurrent pericarditis. In addition, Dr. Al-Kazaz and Dr. Cremer weigh in on the prevalence of pericardial disease across the U.S. Dr. Al-Kazaz is chief of the section of General Cardiology, and Dr. Cremer is the director of Multi-modality Imaging, both at Northwestern Medicine.

Dr. Clyde Yancy, Chief, Division of Cardiology at Bluhm Cardiovascular Institute, joins John Williams to talk about the relationship between health equity and heart care. Why is health equity so important? Dr. Yancy discusses the health disparity to heart health and how Northwestern Medicine is working to improve health equity.

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Clyde Yancy, Chief, Division of Cardiology at Bluhm Cardiovascular Institute, joins John Williams to talk about the relationship between health equity and heart care. Why is health equity so important? Dr. Yancy discusses the health disparity to heart health and how Northwestern Medicine is working to improve health equity.

Dr. Clyde Yancy, Chief, Division of Cardiology at Bluhm Cardiovascular Institute, joins John Williams to talk about the relationship between health equity and heart care. Why is health equity so important? Dr. Yancy discusses the health disparity to heart health and how Northwestern Medicine is working to improve health equity.

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Ike Okwuosa, Director, Infiltrative & Inflammatory Cardiomyopathy Program, Bluhm Cardiovascular Institute, joins John Williams to give us information on heart disease. Dr. Okwuosa tells us about the most common types of heart disease, the symptoms of heart disease that you should be aware of, and the importance of early identification and treatment.

Dr. Ike Okwuosa, Director, Infiltrative & Inflammatory Cardiomyopathy Program, Bluhm Cardiovascular Institute, joins John Williams to give us information on heart disease. Dr. Okwuosa tells us about the most common types of heart disease, the symptoms of heart disease that you should be aware of, and the importance of early identification and treatment.

Dr. Ike Okwuosa, Director, Infiltrative & Inflammatory Cardiomyopathy Program, Bluhm Cardiovascular Institute, joins John Williams to give us information on heart disease. Dr. Okwuosa tells us about the most common types of heart disease, the symptoms of heart disease that you should be aware of, and the importance of early identification and treatment.

In this episode, Ellie Schwab and Yash Kamani discuss all things value based healthcare and population health with Dr. Kannan Mutharasan. Dr. Mutharasan, a practicing Board Certified Cardiologist, brings a unique and interesting perspective to these topics as a clinician on the field.

Up to 25% of all heart patients have advanced heart failure. Mark's guest discusses the benefits that Artificaial Inteligience is giving advance notice on heart failure. Dr. Faraz Ahmad MD is the Associate Director of Northwestern Medicine Bluhm Cardiovascular Institute.More About Dr. Faraz AhmadDr. Ahmad is a practicing heart failure cardiologist who cares for patients across the spectrum of heart failure, including patients with different types of cardiomyopathies, with advanced heart failure, and those who have undergone heart transplantation or mechanical assist device support (LVAD). He has a particular clinical interest in the diagnosis and management of patients with different types of heart failure with preserved ejection fraction, such as cardiac amyloidosis. Dr. Ahmad's research interests are in using data science, machine learning, and digital health technologies to improve quality of care for patients with heart failure and other cardiovascular diseases. His work has received support from multiple organizations, including the National Institutes of Health, the American Heart Association, the Patient-Centered Outcomes Research Institute, the Heart Failure Society of America, and the Centers for Disease Control and Prevention

Up to 25% of all heart patients have advanced heart failure. Mark's guest discusses the benefits that Artificaial Inteligience is giving advance notice on heart failure. Dr. Faraz Ahmad MD is the Associate Director of Northwestern Medicine Bluhm Cardiovascular Institute.More About Dr. Faraz AhmadDr. Ahmad is a practicing heart failure cardiologist who cares for patients across the spectrum of heart failure, including patients with different types of cardiomyopathies, with advanced heart failure, and those who have undergone heart transplantation or mechanical assist device support (LVAD). He has a particular clinical interest in the diagnosis and management of patients with different types of heart failure with preserved ejection fraction, such as cardiac amyloidosis. Dr. Ahmad's research interests are in using data science, machine learning, and digital health technologies to improve quality of care for patients with heart failure and other cardiovascular diseases. His work has received support from multiple organizations, including the National Institutes of Health, the American Heart Association, the Patient-Centered Outcomes Research Institute, the Heart Failure Society of America, and the Centers for Disease Control and Prevention

The American Birkebeiner (Birkie) is an annual cross-country ski marathon located in Hayward, Wisconsin that people from all over the country participate in. The Birkie is made up of several events in addition to the 51K and 55K Birkie marathon races and the 24K Kortelopet race (the second largest ski race in North America). It spans 50 kilometers from Cable, WI to Hayward, WI for Skaters, and 55K for Classic Skiers. In 2020, skiers from 49 States and 27 countries participated.This year, the Birkie will take place the week of February 22 – 26, 2023. In addition to the annual Birkie event, the American Birkebeiner Ski Foundation provides year-round, healthy, active lifestyle events for thousands of adventurous spirits of all ages and abilities. Ben Popp is with Michelle to talk all about it!Winter weather can wreak havoc on your skin and hair. Between all the chapped and cracked skin, and frizzy or damaged hair, this is the time of year to pay extra attention to self-care and beauty routines. Beauty & Fashion Expert, Emily L. Foley is here with a few tips to help us look and feel our best during the colder months. Joe Hart is the President and CEO at Dale Carnegie Training, the most experienced training organization in the world, celebrating 110 years since its founding with operations in over 75 countries and having provided training to tens of millions of people globally. Hart regularly has his writings appear on Newsweek, HR.com, and Rolling Stone, a popular speaker, and co-author of the upcoming book, “TAKE COMMAND: Find your INNER STRENGTH, BUILD ENDURING RELATIONSHIPS, and LIVE THE LIFE YOU WANT” released January 10th, 2023 with Simon and Schuster. The book is inspired by the iconic best seller “How to Win Friends and Influence People” and named after the Top 50 ranked Leadership and Management Podcast Joe hosts, “Take Command: A Dale Carnegie Podcast,” which has included guests ranging from Fortune 500 CEOs to Hall of Fame athletes and fast growing company CEOs. Joe talks to Michelle about how to take command of your own life.Cardiologists at Northwestern Medicine are using AI to identify patients with advanced heart failure who require specialized care, including those who might need ventricular assistance devices or transplant. Heart failure is a common, costly condition affecting over 6 million U.S. adults. That's about 1 in 250 people. When a patient reaches advanced heart failure, medications no longer work. That's why it's vital to catch the problem early.The Center for Artificial Intelligence at the Bluhm Cardiovascular Institute oversees an expansive research and clinical AI program targeting cardiovascular diseases. Dr. Faraz Ahmad is a cardiologist and associalte director of Northwestern Medicine Bluhm Cardiovascular Institiue's Center for Artificial Intelligence. He talks to Michelle about what Northwestern Medicine is doing to help patients.

It's another session of CardioNerds Rounds! In these rounds, Dr. Loie Farina (Advanced Heart Failure and Transplant Fellow at Northwestern University) joins Dr. Jane Wilcox (Chief of the Section of Heart Failure Treatment and Recovery at Northwestern University) to discuss the nuances of HFpEF diagnosis and management. Dr. Wilcox is also the Associate Director of the T1 Center for Cardiovascular Therapeutics in the Bluhm Cardiovascular Institute and Director of the Myocardial Recovery Clinic at Northwestern University. Dr. Wilcox is a prolific researcher, clinician, and thought leader in Heart Failure and we are honored to have her on CardioNerds Rounds! Notes were drafted by Dr. Karan Desai. Audio editing by CardioNerds Academy Intern, student doctor Akiva Rosenzveig. This episode is supported with unrestricted funding from Zoll LifeVest. A special thank you to Mitzy Applegate and Ivan Chevere for their production skills that help make CardioNerds Rounds such an amazing success. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds. Case details are altered to protect patient health information. CardioNerds Rounds is co-chaired by Dr. Karan Desai and Dr. Natalie Stokes.  Speaker disclosures: None Challenging Cases - Atrial Fibrillation with Dr. Hugh Calkins CardioNerds Rounds PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Show notes - Antithrombotic Management with Dr. Deepak Bhatt Case #1 Synopsis: A woman in her 80s with a history of HFpEF presented with worsening dyspnea on exertion over the course of a year but significantly worsening over the past two months. Her other history includes prior breast cancer with chemotherapy and radiation therapy, permanent atrial fibrillation with AV node ablation and CRT-P, and CKD Stage III. She presented for an outpatient RHC with exercise to further characterize her HFpEF. Her echo showed normal LV size, no LVH, LVEF of 50%, decreased RV systolic function, severe left atrial enlargement, significantly elevated E/e' and mild MR. Right heart catheterization showed moderately elevated bi-ventricular filling pressures at rest but with passive leg raise and Stage 1 exercise the wedge pressure rose significantly. We were asked to comment on management. Case #1 Takeaways Amongst the things that were discussed were the role of specific therapies in symptomatic patients with HFpEF. In patients with HFpEF and documented congestion, they will require diuretic therapy for symptomatic relief. But in addition to diuretic therapy, we discussed starting HFpEF-specific therapies. Amongst, those specific therapies mineralocorticoid receptor antagonist (MRA) and sodium-glucose co-transporter 2 (SGLT2) inhibitor. In multiple trials that have included patients with HFPEF, SGLT2i have reduced the risk of hospitalization. This includes the EMPEROR-PRESERVED Trial (see the CardioNerds Journal Club discussion on the trial) in which nearly 6000 patients with NYHA Class II-IV symptoms, EF > 40% and elevated NT-proBNP with a prior HF hospitalization within the past 12 months were randomized to Empagliflozin or placebo. The primary outcome – death from CV causes or hospitalization for Heart Failure – was significantly lower in the SGLT2i arm (13.8% vs 17.1%, 95% CI 0.69-0.90, P 45% to receive either spironolactone or placebo. The primary endpoint (death from CV cause, aborted cardiac arrest, or hospitalization for HF) was not statistically different between treatment arms. Of note, however, there were concerns for regional differences which is outlined well in this NEJM Evidence piece. Case #2 Synopsis: A woman in her 70s with history of hypertension, obesity,

A patient at Northwestern Medicine's Bluhm Cardiovascular Institute is expected to go home this week after receiving the state's first heart donated after circulatory death. Reset learns more from the institute's Dr. Jane Wilcox about how this technology could help save countless lives.

John Howell is joined by Dr. Benjamin Bryner, Associate Director of Heart Transplantation and Mechanical Support, as well as the Director of the Expanded Donation Program at Northwestern Medicine's Bluhm Cardiovascular Institute. Dr. Bryner shares what exactly a  “heart in a box” is, how transplants work in general, and where this program goes from here.  See omnystudio.com/listener for privacy information.

John Howell is joined by Dr. Benjamin Bryner, Associate Director of Heart Transplantation and Mechanical Support, as well as the Director of the Expanded Donation Program at Northwestern Medicine's Bluhm Cardiovascular Institute. Dr. Bryner shares what exactly a  “heart in a box” is, how transplants work in general, and where this program goes from here.  See omnystudio.com/listener for privacy information.

Show Notes - All Things Afib - CAST-AF 2022 with Dr. Bradley KnightSo many legends in the AFib world are excited about the upcoming Catheter and Surgical Therapies for Atrial Fibrillation (CAST AF) Conference happening at the end of August in Chicago. Here to speak with me about some of the sessions is my esteemed guest Dr. Bradley Knight, Director of Cardiac Electrophysiology, Bluhm Cardiovascular Institute of Northwestern at Northwestern Medicine.We'll discuss some of what you'll see and hear at this world-class conference, happening Friday and Saturday, August 26-27 at the Radisson Blu Aqua in Chicago, IL. The talks scheduled are only 10-15 minutes each, with plenty of time built in for questions and discussion after each section. From AI to PFA, wearables, and other forward-looking AFib topics, presenters and technology, register now to attend and get intense, high-yield information, theories, and technology that you can put into practice the very next day you return to work!Dr. Knight is the Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology at Northwestern University, and has been the Director of the Heart Rhythm Program at the BCVI, since November 1, 2009. He earned his BS in Public Health/Biostatistics at the University of North Carolina in Chapel Hill, and his MD at the Ohio State University. After completing his training in Medicine, Cardiology, and Cardiac Electrophysiology at the University of Michigan, he joined the Michigan faculty in 1997. He later served as the Director of Cardiac Electrophysiology at the University of Chicago from 2002 to 2009.As the Medical Director of Cardiac Electrophysiology at Northwestern Medicine, Dr. Knight remains clinically active with a broad range of clinical and research interests in the field of Heart Rhythm Disorders. These interests range from catheter ablation for complex arrhythmias, such as atrial fibrillation, to fundamental issues related to the basic mechanisms of various types of arrhythmias, and the use of imaging in the electrophysiology laboratory to guide ablation procedures and device implantation. He is involved in several multi-center clinical trials that are evaluating novel ablation tools and implantable devices, including the cryoballoon for pulmonary vein isolation, the totally subcutaneous implantable defibrillator, and left atrial appendage occlusion devices. He has coauthored over 300 scientific papers and is on the editorial board of several high-impact medical journals. He has served on the ABIM CCEP Exam Writing Committee for ten years, and is the Editor-in-Chief of the Journal of Cardiovascular Electrophysiology (JCE) and EPLab Digest.All Things Afib is hosted by me, Dr. Armin Kiankhooy. As a board-certified cardiothoracic surgeon, my focus is on advanced treatments for heart and lung failure and minimally-invasive surgical treatments for atrial fibrillation such as the Hybrid Maze procedure. You can find me on staff at Adventist Health Heart and Vascular Institute in St. Helena California. Discussion points:This may be the best conference happening in the world todayFocus on interventional therapiesStructure of the conference, short and intense for high-yield informationThe collaborative methods in practice at NorthwesternHot Topic: Pulse Field Ablation and it's many advantagesTalking tech: Devices and wearablesThe new approaches - using anticoags, closing the left atriral appendage, LAOS III and reducing stroke risksTraining programs at Northwestern – new opportunitiesThe differences in training from only ten years ago are staggeringRegister to attend today!Resources:Dr. Bradley Knight LinkedInDr. Bradley Knight TwitterCATH AF 2022Dr. Kiankhooy LinkedInAll Things AFib WebsiteAll Things AFib TwitterAll Things AFib YouTube Channel

Dr. Clyde Yancy, Chief of Cardiology and Associate Medical director of the Bluhm Cardiovascular Institute at Northwestern Medicine, joins John Williams to discusses diversity and inclusion efforts at Northwestern Medicine. Dr. Clyde Yancy explains that the “new generation” of Northwestern Medicine is focused on ensuring access to high quality and culturally sensitive care for Chicago […]

Dr. Clyde Yancy, Chief of Cardiology and Associate Medical director of the Bluhm Cardiovascular Institute at Northwestern Medicine, joins John Williams to discusses diversity and inclusion efforts at Northwestern Medicine. Dr. Clyde Yancy explains that the “new generation” of Northwestern Medicine is focused on ensuring access to high quality and culturally sensitive care for Chicago […]

I'm speaking with Dr. Patrick M. McCarthy, a Board Certified Thoracic and Cardiac Surgeon, currently the Executive Director of the Bluhm Cardiovascular Institute, and Chief of Cardiac Surgery at the Feinberg School of Medicine at Northwestern. His list of honors and awards is extensive, and his focus and specialties include:Valve Repair/ReplacementMitral Valve RepairAtrial Fibrillation SurgeryMaze ProcedureAortic AneurysmCoronary Bypass SurgeryHypertrophic Cardiomyopathy / MyectomyMinimally Invasive SurgeryJoin us as we discuss Dr. McCarthy's findings and how they have affected, or should affect, treatments and surgeries for AFib.Discussion points:Introduction and background – Dr. Patrick M. McCarthyWhy this paper? Why was it necessary?When you think about the industry before this paper, what percentage had AFib pre-surgery?How AFib nurses at Northwestern identify AFib patients pre-surgeryPercentages of mitral valve surgical patients with AFib before surgerySurgeons MUST discuss and find any history of AFib with patients before surgeryHow should we screen for AFib?Why were certain female/diabetic patients in the study not treated?Why aren't more surgeons treating AFib?How Dr. McCarthy's trainees are educated re: treating AFibDiscussion of the newer variations on the Maze IV procedureIt only takes a total of about 8 minutes for the cryoablation procedure, so there's no excuse not to treatSurgeons need about 5 surgeries to master the procedureMcCarthy's message to surgeons: Don't shy away, its easier to learn these days, and should be performedResources:Link to the published paper: Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablationDr. Patrick McCarthy at Northwestern U.Dr. Kiankhooy LinkedInAll Things AFib WebsiteAll Things AFib TwitterAll Things AFib YouTube Channel

Dr. Patrick McCarthy, Executive Director of Bluhm Cardiovascular Institute and Chief of Cardiac Surgery in the Department of Surgery at Northwestern Medicine, joined the podcast to talk about system integrations, AI in cardiology and the future of medicine.

Dr. Patrick McCarthy, Executive Director of Bluhm Cardiovascular Institute and Chief of Cardiac Surgery in the Department of Surgery at Northwestern Medicine, joined the podcast to talk about system integrations, AI in cardiology and the future of medicine.

Ben Levin is an autistic teenage who has been in love with stories ever since he was a little boy and is the author of multiple books, including the breakout novel, "In the Hole." Dr. James Thomas, director of the Center for Heart Valve Disease and Academic Affairs at the Bluhm Cardiovascular Institute at Northwestern Medicine, talks about how AI is helping the management of cardiovascular disease. Kevin Schewe is the author of the Bad Love Book Series and a board-certified cancer specialist who has been in the private practice of radiation oncology for over 34 years. Check out his newest novel, Bad Love Medicine. Justina Nixon is the IBM VP and Global Head, Corporate Social Responsibility. She talks about her digital training program, Skills Build. It offers over 1,000 online courses.

James D. Thomas, MD, is a cardiologist at Northwestern Medicine with a clinical focus in valvular heart disease and echocardiography and extensive research into applying physical principles and advanced technology in cardiovascular imaging. He now serves as Director for the Center for Heart Valve Disease and Academic Affairs in the Bluhm Cardiovascular Institute and co-directs the Center for Artificial Intelligence in Cardiovascular Disease while serving as Professor of Medicine at Northwestern University Feinberg School of Medicine.  The Bluhm Cardiovascular Institute is also pioneering the use of a digital stethoscope that uses AI algorithms to accurately interpret heart sounds to help screen for heart murmurs and valvular heart disease. Sounds like a winner Doc Response: ... (The basic stethoscope design hasn't changed in 200 years, so it's due for an upgrade. Initial work, recently published, demonstrated that it could identify 93% of patients with severe aortic stenosis. This new AI-platform could be a more reliable, low-cost way to identify patients with heart disease.)   Another initiative within the Bluhm Cardiovascular Institute Center for Artificial Intelligence in Cardiovascular Medicine is a unique collaboration with Northwestern University computer scientists centered on deep-learning techniques. In a first-of-its-kind intensive Masters-level fellowship, trainees in cardiology and cardiac surgery learn the tools and techniques of AI programming and apply this methodology to heart disease. These unique doctors aim to be the leaders in this rapidly evolving field.  For more information, please visit www.nm.org/radioRecommended by Dr. Jim Thomas - Director for the Center for Heart Valve Disease and Academic Affairs in the Bluhm Cardiovascular Institute at Northwestern Medicine. The Institute for Augmented Intelligence Medicine https://www.feinberg.northwestern.edu/sites/augmented-intelligence/ The mission of the Institute for Augmented Intelligence in Medicine is to bridge computational methods with human expertise to advance medical science and improve human health. A person smiling for the pictureDescription automatically generated with low confidenceWe explore the application of machine learning, artificial intelligence, pattern recognition, genetic analysis and deep phenotyping of health data to build useful, responsible tools that put people first. Abel Kho, MD, MS, FACMI, Director, Institute for Augmented Intelligence in Medicine

James D. Thomas, MD, is a cardiologist at Northwestern Medicine with a clinical focus in valvular heart disease and echocardiography and extensive research into applying physical principles and advanced technology in cardiovascular imaging. He now serves as Director for the Center for Heart Valve Disease and Academic Affairs in the Bluhm Cardiovascular Institute and co-directs the Center for Artificial Intelligence in Cardiovascular Disease while serving as Professor of Medicine at Northwestern University Feinberg School of Medicine.  The Bluhm Cardiovascular Institute is also pioneering the use of a digital stethoscope that uses AI algorithms to accurately interpret heart sounds to help screen for heart murmurs and valvular heart disease. Sounds like a winner Doc Response: ... (The basic stethoscope design hasn't changed in 200 years, so it's due for an upgrade. Initial work, recently published, demonstrated that it could identify 93% of patients with severe aortic stenosis. This new AI-platform could be a more reliable, low-cost way to identify patients with heart disease.)   Another initiative within the Bluhm Cardiovascular Institute Center for Artificial Intelligence in Cardiovascular Medicine is a unique collaboration with Northwestern University computer scientists centered on deep-learning techniques. In a first-of-its-kind intensive Masters-level fellowship, trainees in cardiology and cardiac surgery learn the tools and techniques of AI programming and apply this methodology to heart disease. These unique doctors aim to be the leaders in this rapidly evolving field.  For more information, please visit www.nm.org/radioRecommended by Dr. Jim Thomas - Director for the Center for Heart Valve Disease and Academic Affairs in the Bluhm Cardiovascular Institute at Northwestern Medicine. The Institute for Augmented Intelligence Medicine https://www.feinberg.northwestern.edu/sites/augmented-intelligence/ The mission of the Institute for Augmented Intelligence in Medicine is to bridge computational methods with human expertise to advance medical science and improve human health. A person smiling for the pictureDescription automatically generated with low confidenceWe explore the application of machine learning, artificial intelligence, pattern recognition, genetic analysis and deep phenotyping of health data to build useful, responsible tools that put people first. Abel Kho, MD, MS, FACMI, Director, Institute for Augmented Intelligence in Medicine

Dr. Patrick McCarthy, Executive Director of Bluhm Cardiovascular Institute and Chief of Cardiac Surgery in the Department of Surgery at Northwestern Medicine, joined the podcast to talk about system integrations, AI in cardiology and the future of medicine.

In this Giants of Cardiothoracic Surgery interview, Joel Dunning speaks with Patrick M. McCarthy, executive director of the Bluhm Cardiovascular Institute at Northwestern in Chicago, Illinois. They discuss Dr McCarthy's training and mentorship, his techniques with mitral valve surgery, and how the field has changed over the course of his career.

The Northwestern Medicine Cardiovascular Genetics Program at the Bluhm Cardiovascular Institute provides comprehensive cardiovascular care encompassing genetic testing and medical management for all forms of inherited cardiovascular diseases.Jane E. Wilcox, MD, MSc discusses the role of genetics in the etiology of heart failure. She shares some of the challenges that exist in identifying the genetic determinants of common, complex diseases such as CHD and how with the use of genetic testing, the ability to diagnose those who are at risk for heart disease before it has developed, can help to assure the latest treatments for the best patient outcomes.

A new medical device may help better treat and prevent strokes for hundreds of thousands of people in the U.S.Atrial fibrillation, or flutter, is a common type of abnormal heartbeat and has been linked to risk of stroke. In this condition, the heart rhythm is fast and irregular. Atrial fibrillation may occur without your knowledge, causing you not to seek medical attention and thus increase your risk of death from stroke.Atrial fibrillation is the most common abnormal rhythm of the heart, and at least five million Americans suffer from the condition.What if there was something that could help prevent strokes from happening in those who suffer from atrial fibrillation, other than medication?A new device about the size of a AAA battery can be injected into your skin. This device then automatically hooks up with a bedside transponder. If you have any abnormal rhythms in your heart, it will find the nearest cell phone tower and transmit that information to your caregiver.Doctors will now be able to tell when you've had an abnormal rhythm, even if you can't.In a Northwestern Medicine study, researchers monitored people with cryptogenic strokes for intermittent atrial fibrillation using the new device. The device detected atrial fibrillation in 30 percent of people with cryptogenic stroke.Using standard techniques, physicians only found atrial fibrillation in about three percent of these patients. Because of these results, those 30 percent of patients were almost all switched to blood thinners. This treatment action should protect them from having another stroke.Medical director for the Program for Atrial Fibrillation at the Bluhm Cardiovascular Institute, associate director of Cardiac Electrophysiology, and a member of the Northwestern Medical Faculty Foundation, Rod S. Passman, MD, shares the alarming risks of atrial fibrillation, new research that helps connect the link between atrial fibrillation and stroke and a new treatment option.

A new medical device may help better treat and prevent strokes for hundreds of thousands of people in the U.S.Atrial fibrillation, or flutter, is a common type of abnormal heartbeat and has been linked to risk of stroke. In this condition, the heart rhythm is fast and irregular. Atrial fibrillation may occur without your knowledge, causing you not to seek medical attention and thus increase your risk of death from stroke.Atrial fibrillation is the most common abnormal rhythm of the heart, and at least five million Americans suffer from the condition.What if there was something that could help prevent strokes from happening in those who suffer from atrial fibrillation, other than medication?A new device about the size of a AAA battery can be injected into your skin. This device then automatically hooks up with a bedside transponder. If you have any abnormal rhythms in your heart, it will find the nearest cell phone tower and transmit that information to your caregiver.Doctors will now be able to tell when you've had an abnormal rhythm, even if you can't.In a Northwestern Medicine study, researchers monitored people with cryptogenic strokes for intermittent atrial fibrillation using the new device. The device detected atrial fibrillation in 30 percent of people with cryptogenic stroke.Using standard techniques, physicians only found atrial fibrillation in about three percent of these patients. Because of these results, those 30 percent of patients were almost all switched to blood thinners. This treatment action should protect them from having another stroke.Medical director for the Program for Atrial Fibrillation at the Bluhm Cardiovascular Institute, associate director of Cardiac Electrophysiology, and a member of the Northwestern Medical Faculty Foundation, Rod S. Passman, MD, shares the alarming risks of atrial fibrillation, new research that helps connect the link between atrial fibrillation and stroke and a new treatment option.

Guest: Neil Stone, MD Host: Alan S. Brown, MD, FNLA Why is metabolic syndrome so important if it's not a disease? What have we learned from clinical trials about treating metabolic syndrome with lifestyle and/or drugs? And, what hurdles does the clinician face in trying to improve metabolic syndrome variables in the individual patient? Join Host Dr. Alan Brown as he welcomes Dr. Neil J Stone who will answer these questions and more. Dr. Stone is the Bonow Professor of Medicine at The Feinberg School of Medicine of Northwestern University and Distinguished Physician and Medical Director of the Vascular Center of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital in Chicago, Illinois.

Guest: Kim Lebowitz Host: Lauren Streicher, MD Women are twice as likely as men to experience depression, and that statistic holds true for female cardiac patients. Linking heart disease and depression, the American Heart Association recently recommended that all cardiac patients be screened for depression. Dr. Kim Lebowitz, director and founder of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital in Chicago, discusses with host Dr. Lauren Streicher the new field of cardiac psychology and how doctors can screen their cardiac patients for the signs and symptoms of depression.

Guest: Kim Lebowitz Host: Lauren Streicher, MD Women are twice as likely as men to experience depression, and that statistic holds true for female cardiac patients. Linking heart disease and depression, the American Heart Association recently recommended that all cardiac patients be screened for depression. Dr. Kim Lebowitz, director and founder of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital in Chicago, discusses with host Dr. Lauren Streicher the new field of cardiac psychology and how doctors can screen their cardiac patients for the signs and symptoms of depression.

Host: Lauren Streicher, MD Guest: Marla Mendelson, MD Marfan Syndrome, an inherited connective tissue disorder, affects 1 in 10,000 to 1 in 20,000 individuals. Women with Marfan Syndrome have a wide range of abnormalities involving the lungs, skin, ocular, musculoskeletal and cardiovascular systems. Today we are joined by Dr. Marla A. Mendelson, an assistant professor of Medicine at Northwestern University’s Feinberg School of Medicine, and director of the Women’s Cardiology program of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital which has just opened a clinic devoted to the management of women with Marfan syndrome.

Host: Lauren Streicher, MD Guest: Marla Mendelson, MD Marfan Syndrome, an inherited connective tissue disorder, affects 1 in 10,000 to 1 in 20,000 individuals. Women with Marfan Syndrome have a wide range of abnormalities involving the lungs, skin, ocular, musculoskeletal and cardiovascular systems. Today we are joined by Dr. Marla A. Mendelson, an assistant professor of Medicine at Northwestern University’s Feinberg School of Medicine, and director of the Women’s Cardiology program of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital which has just opened a clinic devoted to the management of women with Marfan syndrome.

Host: Lauren Streicher, MD Guest: Marla Mendelson, MD Marfan Syndrome, an inherited connective tissue disorder, affects 1 in 10,000 to 1 in 20,000 individuals. Women with Marfan Syndrome have a wide range of abnormalities involving the lungs, skin, ocular, musculoskeletal and cardiovascular systems. Today we are joined by Dr. Marla A. Mendelson, an assistant professor of Medicine at Northwestern University’s Feinberg School of Medicine, and director of the Women’s Cardiology program of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital which has just opened a clinic devoted to the management of women with Marfan syndrome.